-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Downgrades DiaSorin to Sell Rating, Cuts PT

MT Newswires·08/12/2026 08:32:19
Listen to the news
08:32 AM EDT, 08/12/2026 (MT Newswires) -- UBS on Wednesday downgraded biotechnology company DiaSorin (DIA.MI) to sell from neutral and reduced its price target to 55.00 euros from 66.00 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)